A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries
In response to higher drug spending growth and heightened attention to drug prices, policymakers have proposed a variety of policy initiatives to lower the cost of prescription drugs in Medicare. This brief examines in detail the range of proposals offered by the Trump Administration and members of Congress for lowering the cost of prescription drugs, their known effects on the federal budget, and their potential implications for beneficiaries and other stakeholders.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed